This company has been marked as potentially delisted and may not be actively trading. (RRMS) (RRMS) News Today Add Share Share Headlines Stock AnalysisBuy This Stock RRMS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Tysabri (natalizumab) Market Research Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2034May 8, 2025 | finance.yahoo.comAI analyzes patient data to detect multiple sclerosis progression, improving early treatment decisionsApril 29, 2025 | msn.comAI model enhances early diagnosis of multiple sclerosisApril 28, 2025 | msn.comIs Selma Blair game for reprising the icy Vivian in 'Legally Blonde 3?'March 7, 2025 | msn.comData of InnoCare's Orelabrutinib for the Treatment of MS Released at 2025 ACTRIMS ForumFebruary 26, 2025 | finance.yahoo.comContineum concludes enrolment in Phase II multiple sclerosis therapy trialJanuary 9, 2025 | finance.yahoo.comHallmark Channel Responds to ‘Outrageous’ Claims in Bombshell LawsuitOctober 29, 2024 | msn.comMean Girls star Lacey Chabert ‘getting old’ for Hallmark? Network hit with age discrimination lawsuitOctober 25, 2024 | msn.comMean Girls star Lacey Chabert ‘getting old’ for Hallmark? Network hit with age discrimination lawsuitOctober 25, 2024 | msn.comHallmark stars Lacey Chabert and Holly Robinson Peete allegedly 'too old' for company, per new lawsuitOctober 25, 2024 | msn.comHallmark stars Lacey Chabert and Holly Robinson Peete allegedly 'too old' for company, per new lawsuitOctober 25, 2024 | msn.comPolTREG launches Phase 2 cell therapy trial in children with presymptomatic diabetesOctober 24, 2024 | markets.businessinsider.comTherapies for Multiple SclerosisOctober 19, 2024 | msn.comMultiple Sclerosis Drug Pipeline Research Report 2024: Therapeutic Assessment, Emerging Drugs, Pipeline Development Activities, Competitive LandscapeOctober 14, 2024 | finance.yahoo.comSetPoint’s neuromodulation implant wins IDE for multiple sclerosis studyOctober 3, 2024 | finance.yahoo.comFar-right party wins Austria election, adds to EU right wing surgeSeptember 30, 2024 | msn.comEuropean Committee for Treatment and Research in Multiple Sclerosis, Sept. 18-20September 28, 2024 | msn.comPolTREG starts preclinical CAR-Treg development for neuroinflammatory autoimmune diseasesSeptember 26, 2024 | tmcnet.comBillionaire Binance Founder Changpeng Zhao Slated For Prison Release On September 29September 16, 2024 | benzinga.comPolTREG S.A.: China patent notification boosts PolTREG's development of Treg cell therapy in multiple sclerosisSeptember 16, 2024 | finanznachrichten.deChina patent notification boosts PolTREG’s development of Treg cell therapy in multiple sclerosisSeptember 16, 2024 | markets.businessinsider.comPolTREG Treg cell therapy for patients with type-1 diabetes shows long-term clinical remission and insulin independenceSeptember 9, 2024 | tmcnet.comRiley Shepard Details Her Journey With Relapsing-Remitting Multiple Sclerosis, Knee Injuries, And Potential Future In WrestlingSeptember 4, 2024 | yahoo.comEx-Commissioner Sammie Sias returns back to GeorgiaSeptember 3, 2024 | msn.comHow Progressive Multiple Sclerosis Differs From Relapsing-Remitting MSAugust 27, 2024 | msn.comFor Your Patients: Understanding Progressive MS and Relapsing MSAugust 27, 2024 | msn.comMultiple Sclerosis (MS) Diagnosis and Treatment Market Size to Reach USD 30.28 Bn by 2032August 26, 2024 | finance.yahoo.comWhat to Know About MS and FatigueAugust 19, 2024 | msn.comChef Kevin Gillespie Unveils Nadair: A Scottish-Inspired Dining ExperienceAugust 17, 2024 | msn.comContineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business HighlightsAugust 13, 2024 | finance.yahoo.comPoll Shifts and Political Drama: How Kamala Harris is Gaining Ground on TrumpAugust 12, 2024 | msn.comAddressing Healthcare Disparities and Public Safety in GeorgiaAugust 8, 2024 | msn.comAtlanta’s Human Relations Commission: Key Insights UpdateAugust 6, 2024 | msn.comTG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue GuidanceAugust 6, 2024 | finance.yahoo.comFulton Housing Auth. Chair Atty Weems Fires Back, Files Legal MotionsJuly 30, 2024 | msn.comBlack Belt Eagle Scout Starts GoFundMe After “Medical Emergency” Forces Show CancellationsJuly 24, 2024 | msn.comBlack Belt Eagle Scout Launches Fundraiser Following ‘Frightening Medical Emergency'July 24, 2024 | msn.comBlack Belt Eagle Scout Launches Fundraiser Following ‘Frightening Medical Emergency’July 23, 2024 | yahoo.comBureau Of Prisons’ Video On First Step Act Lays Out ProgramJuly 20, 2024 | forbes.comTreatment hopes dashed for MS sufferersMay 14, 2024 | msn.comMorgan Stanley Predicts up to 110% Rally for These 2 ‘Strong Buy’ StocksMay 8, 2024 | msn.comImmunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journalMay 1, 2024 | finance.yahoo.comMultiple Sclerosis Market To Reach USD 39.9 Billion By 2032, Report By DataHorizzon ResearchApril 26, 2024 | finance.yahoo.comGranite Telecommunications Boosts EPIK Solution with Strategic Rapid Response Monitoring AllianceApril 10, 2024 | finance.yahoo.comPolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Treg therapy in combination with rituximabApril 4, 2024 | markets.businessinsider.comHow Everclear’s Art Alexakis combines rock and comedy to fight MSMarch 27, 2024 | msn.comWhen Does SPMS Begin?March 25, 2024 | msn.comSetPoint joins FDA’s TAP programme with MS deviceMarch 22, 2024 | msn.comUnveiling Atlanta's Culinary Gems with Mike Jordan and Max HinesMarch 15, 2024 | msn.comSetPoint wins second FDA breakthrough device nod for neurostim deviceMarch 14, 2024 | msn.com Get (RRMS) News Delivered to You Automatically Sign up to receive the latest news and ratings for RRMS and its competitors with MarketBeat's FREE daily newsletter. Email Address RRMS Media Mentions By Week RRMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RRMS News Sentiment▼0.001.39▲Average News Sentiment RRMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RRMS Articles This Week▼00▲RRMS Articles Average Week Get (RRMS) News Delivered to You Automatically Sign up to receive the latest news and ratings for RRMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RRMS) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (RRMS) Please log in to your account or sign up in order to add this asset to your watchlist. Share (RRMS) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.